Back
Sonoma Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
SNOA
Sponsored
9,530x the last time this happened
Here's what our expert says you should buy before April 14.
Sell
20
SNOA
Sonoma Pharmaceuticals
Last Price:
0.16
Seasonality Move:
4.26%
7 Day Trial
ALL ACCESS PASS
$
7
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.Sonoma Pharmaceuticals Price Quote
$0.16
0.00 (-0.25%)
(Updated: April 26, 2024 at 6:55 PM ET)
Sonoma Pharmaceuticals Key Stats
Sell
20
Sonoma Pharmaceuticals (SNOA)
is a Sell
Day range:
$0.16 - $0.17
52-week range:
$0.12 - $1.52
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.08
P/B ratio:
0.37%
Volume:
112.3K
Avg. volume:
623K
1-year change:
-84.12%
Market cap:
$2.5M
Revenue:
$13.3M
EPS:
$-0.94
How Much Does Sonoma Pharmaceuticals Make?
-
How Much Are Sonoma Pharmaceuticals's Sales Annually?
SNOA Revenues are $13.3M -
How Much Profit Does Sonoma Pharmaceuticals's Make A Year?
SNOA net income is -$5.2M
Is Sonoma Pharmaceuticals Growing As A Company?
-
What Is Sonoma Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.07% -
What Is Sonoma Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Sonoma Pharmaceuticals Stock Price Performance
-
Did Sonoma Pharmaceuticals Stock Go Up Last Month?
Sonoma Pharmaceuticals share price went up by 14.57% last month -
Did SNOA's Share Price Rise Over The Last Year?
SNOA share price fell by -84.12% over the past 1 year
What Is Sonoma Pharmaceuticals 52-Week High & Low?
-
What Is Sonoma Pharmaceuticals’s 52-Week High Share Price?
Sonoma Pharmaceuticals has traded as high as $1.52 over the past 52 weeks -
What Is Sonoma Pharmaceuticals’s 52-Week Low Share Price?
Sonoma Pharmaceuticals has traded as low as $0.12 over the past 52 weeks
Sonoma Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Sonoma Pharmaceuticals?
-
How Much Debt Does Sonoma Pharmaceuticals Have?
Total long term debt quarterly is $44K -
How Much Cash Does Sonoma Pharmaceuticals Have?
Cash and short term investments quarterly total is $2.4M -
What Is Sonoma Pharmaceuticals’s Book Value Per Share?
Book value per share is 0.49
Is Sonoma Pharmaceuticals Cash Flow Positive?
-
What Is SNOA Cash Flow From Operations?
Cash flow from operations (TTM) is -$5M -
What Is Sonoma Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $4.4M -
What Is Sonoma Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$102K
Sonoma Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
SNOA return on invested capital is -74.41% -
What Is Sonoma Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -34.16% -
What Is SNOA Return On Equity?
ROE is a measure of profitability and is -76.57%
Sonoma Pharmaceuticals Earnings Date & Stock Price
-
What Is Sonoma Pharmaceuticals's Stock Price Today?
A single share of SNOA can be purchased today for 0.16 -
What Is Sonoma Pharmaceuticals’s Stock Symbol?
Sonoma Pharmaceuticals trades on the nasdaq under the ticker symbol: SNOA -
When Is Sonoma Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Sonoma Pharmaceuticals is scheduled on May 31, 2024 -
When Is SNOA's next ex-dividend date?
Sonoma Pharmaceuticals's next ex-dividend date is April 27, 2024 -
How To Buy Sonoma Pharmaceuticals Stock?
You can buy Sonoma Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Sonoma Pharmaceuticals Competitors
-
Who Are Sonoma Pharmaceuticals's Competitors?
Below is a list of companies who compete with Sonoma Pharmaceuticals or are related in some way:
Sonoma Pharmaceuticals Dividend Yield
Data Unavailable
Sonoma Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 6.59% | -16.54% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 3.25 |
Upside from Last Price: | 1926.18% |